Completed A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants NCT04335539 Conditions Bacterial Infections, Bacterial Infections and Mycoses, Bloodstream Infections (BSI), +20 more Locations Universitair Ziekenhuis Brussel — Brussels, Belgium Cliniques Universitaires Saint-Luc — Brussels, Belgium Tallinn Childrens Hospital — Tallinn, Estonia Tartu Ulikooli Kliinikum - Anestesioloogia ja Intensiivravi Kliinik — Tartu, Estonia View all 23 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens NCT02714595 Conditions Bloodstream Infections (BSI), Complicated Urinary Tract Infection (cUTI), Cross Infection, +17 more Locations Shionogi Research Site — Hartford, Connecticut, United States Shionogi Research Site — Newark, Delaware, United States Shionogi Research Site — Chicago, Illinois, United States Shionogi Research Site — New Orleans, Louisiana, United States View all 85 locations View more locations Show fewer locations Loading locations... View Trial Details
